TABLE 2.
HPV prevalence in cervical specimens by cytological diagnosis and final outcome: comparison between the AMPLICOR HPV Test and HC2 assay
| Diagnosis or final outcome | No. (%) of positive samples
|
Total no. of cases | |
|---|---|---|---|
| HC2 | AMPLICOR | ||
| Cytological diagnoses (n = 930) | |||
| Negative | 252 (38.1) | 201 (30.5) | 660 |
| ASC-US/AGC-US | 53 (36.5) | 48 (33.1) | 145 |
| LSIL | 47 (90.4) | 45 (86.5) | 52 |
| HSIL | 73 (100) | 73 (100) | 73 |
| Final outcomes (n = 416) | |||
| Negative | 165 (67.6) | 124 (50.8) | 244 |
| CIN1 | 62 (78.4) | 57 (72.1) | 79 |
| CIN2+ | 91 (97.8) | 90 (96.7) | 93 |